Certified by Founder Lodge
3B Future Health Fund I & II
Germany - Luxembourg
INVESTOR
1 Disclosed Funding Rounds $5,000,000
5 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
3B Future Health Fund is an investment fund with focus on early-stage investment opportunities in areas of high unmet patient need, mainly oncology and rare disease therapeutics.
We focus o
| Company | Date | Round | Raised |
|---|---|---|---|
 Geneos Therapeutics |
April, 13 ,2023 | Series A | $5,000,000 |
 OncoResponse |
May, 19 ,2023 | Unknown | $14,000,000 |
 Fore Biotherapeutics |
August, 25 ,2023 | Series D | $75,000,000 |
 NeoPhore Ltd |
February, 02 ,2024 | Series B | $12,245,712 |
 Epsilogen Ltd |
September, 10 ,2024 | Series B | $16,370,899 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Transaera, Inc. | $10,500,000 | (Nov 5, 2024)
Algebrik AI | $4,000,000 | (Nov 5, 2024)
Insider. | $500,000,000 | (Nov 5, 2024)
Cintoo | $40,246,701 | (Nov 5, 2024)
Advex AI | $3,500,000 | (Nov 5, 2024)
